previously General Manager of Raptec’s OEM Solutions Group; and R. Elliot Maxter,
CFO, and previously corporate controller for Raptec. The interim four-member board of
directors is currently comprised of Raptec senior officers, but the terms of the public
offering require them to step down in 2 months. Thus, Axio will need to construct a new
board, which in turn will be responsible for overseeing Axio’s management and their
compensation.
How should the board design the executive compensation scheme for Luthor, Kool, and
Maxter?
CaseScenario2:Compliance,Inc.
Compliance, Inc. (CI) conducts clinical human and animal trials for the pharmaceutical
and biotechnology industries. Revenues are split evenly between early and late drug
development services and the firm is a leader in the laboratory technologies needed for
such testing. One of CI’s internal quality managers, Sharon Kline, has approached the
CEO with a new business proposal. She would like to see the firm take one of its
in-house software programs and develop it as a leadingÂedge commercial product for
three specific target markets€medical care providers, payers of medical care, like
insurance companies, and suppliers to medical care providers, like pharmaceutical
companies. The features of the software are easy to use and include electronic
distribution, data harvesting, and robust reporting capabilities. With this software
Sharon believes that medical care providers will be able to collect data to market to and
negotiate contracts with payers or employers, profile performance of individual
physicians or practice sites, identify best clinical practices, generate reports that satisfy
regulatory or accreditation requirements for provider sites, and supply professional
societies with data for influencing payer and government policies. Another target